UK's MHRA allows early access to lumasiran for ultra-rare disease

16th July 2020 Uncategorised 0

Lumasiran targets primary hyperoxaluria type 1 (PH1), which affects just around 90 people in the UK and one to three individuals per million in Europe

More: UK's MHRA allows early access to lumasiran for ultra-rare disease
Source: News